Shanghai Shyndec Pharmaceutical Co., Ltd. Class ASSE: 600420

Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs

· Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment